In Brief: Gene therapy public conference

Gene therapy public conference: FDA will sponsor a public conference July 11-12 on gene therapy development and evaluation of Phase I products and vector development, according to an April 29 Federal Register notice. The conference will touch on the investigational new drug process, points-to-consider documents and resources available from the National Institutes of Health to bring products into clinical trials. The conference will be held at the NIH Natcher Auditorium in Bethesda, Md., beginning at 8 a.m. both days...